| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | NEUTRAL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 0.57▼ | 0.57▼ | 0.57▲ | 0.53▲ | 0.56▲ |
| MA10 | 0.56▲ | 0.56▲ | 0.56▲ | 0.54▲ | 0.56▼ |
| MA20 | 0.56▲ | 0.55▲ | 0.54▲ | 0.56▼ | 0.55▲ |
| MA50 | 0.53▲ | 0.53▲ | 0.53▲ | 0.58▼ | 0.90▼ |
| MA100 | 0.52▲ | 0.54▲ | 0.56▲ | 0.55▲ | 1.88▼ |
| MA200 | 0.54▲ | 0.57▼ | 0.58▼ | 0.78▼ | 5.37▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.001▼ | 0.001▲ | 0.004▲ | -0.001▼ | 0.037▲ |
| RSI | 62.340▲ | 60.956▲ | 60.741▲ | 50.643▲ | 42.119▼ |
| STOCH | 88.712▲ | 85.589▲ | 79.233 | 42.642 | 39.573 |
| WILL %R | -15.663▲ | -8.125▲ | -8.125▲ | -54.556 | -59.114 |
| CCI | 47.435 | 68.246 | 82.206 | 56.981 | -77.806 |
|
Friday, August 15, 2025 02:24 AM
Patient dosing ongoing in CALiPSO-1 trial; on track to report clinical data for CNTY-101 in patients with B-cell-mediated autoimmune diseases by year-end 2025CNTY-308, a CAR-iT cell therapy functional ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 15/08/25 | 0.5732 | 0.5799 | 0.55 | 0.5618 | 784,558 |
| 14/08/25 | 0.53 | 0.575 | 0.523 | 0.55 | 1,138,707 |
| 13/08/25 | 0.53 | 0.5584 | 0.5206 | 0.5332 | 632,091 |
| 12/08/25 | 0.49 | 0.523 | 0.48 | 0.518 | 910,712 |
| 11/08/25 | 0.51 | 0.5499 | 0.4822 | 0.4896 | 916,939 |
| 08/08/25 | 0.536 | 0.55 | 0.502 | 0.5073 | 655,482 |
| 07/08/25 | 0.5429 | 0.57 | 0.52 | 0.5292 | 419,846 |
| 06/08/25 | 0.5583 | 0.5697 | 0.53 | 0.5424 | 518,006 |
| 05/08/25 | 0.5728 | 0.5728 | 0.5402 | 0.558 | 302,092 |
| 04/08/25 | 0.5367 | 0.5699 | 0.53 | 0.5649 | 625,951 |
|
|
||||
|
|
||||
|
|